Compare GTE & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTE | TMCI |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.1M | 174.6M |
| IPO Year | N/A | 2021 |
| Metric | GTE | TMCI |
|---|---|---|
| Price | $4.14 | $2.48 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.87 |
| AVG Volume (30 Days) | 531.6K | ★ 835.7K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $611,444,000.00 | $218,879,000.00 |
| Revenue This Year | $4.87 | $3.25 |
| Revenue Next Year | N/A | $0.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $3.09 | $2.36 |
| 52 Week High | $8.19 | $10.79 |
| Indicator | GTE | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 30.57 |
| Support Level | $3.81 | $2.36 |
| Resistance Level | $4.37 | $2.63 |
| Average True Range (ATR) | 0.25 | 0.18 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 39.90 | 19.33 |
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.